| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1221196 | Journal of Pharmaceutical and Biomedical Analysis | 2015 | 4 Pages |
•A rapid HPLC-CAD method for the determination of polidocanol was developed.•Validation as potential compendial method for content determination was performed.•The method was applied to assess the polidocanol release from a polymer matrix.
Currently, neither the European nor the United States Pharmacopoeia provide a method for the determination of polidocanol (PD) content despite the fact that PD, besides being an excipient, is also used as an active pharmaceutical ingredient. We therefore developed a method where the PD content was determined using a Kinetex C18 column operated at 40 °C with water–acetonitrile (15:85, v/v) as mobile phase. A Corona® charged aerosol detector was employed for the detection of PD that is lacking a suitable UV chromophore. The method was fully validated. Additionally, the method was applied for the determination of PD release from a pharmaceutical polymer matrix consisting of poly-ɛ-caprolactone and poly(lactic-co-glycolic acid) and PD.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
